Innovating in the medical device industry – challenges & opportunities ESB 2015 translational research symposium

被引:0
|
作者
Y. Bayon
M. Bohner
D. Eglin
P. Procter
R.G. Richards
J. Weber
D.I. Zeugolis
机构
[1] Medtronic – Sofradim Production,Regenerative, Modular & Developmental Engineering Laboratory (REMODEL)
[2] Dr Robert Mathys Foundation,Centre for Research in Medical Devices (CÚRAM)
[3] AO Research Institute Davos,undefined
[4] Medical Device Industry Consultant,undefined
[5] Boston Scientific,undefined
[6] National University of Ireland Galway (NUI Galway),undefined
[7] National University of Ireland Galway (NUI Galway),undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The European Society for Biomaterials 2015 Translational Research Symposium focused on ‘Innovating in the Medical Device Industry – Challenges & Opportunities’ from different perspectives, i.e., from a non-profit research organisation to a syndicate of small and medium-sized companies and large companies. Lecturers from regulatory consultants, industry and research institutions described the innovation process and regulatory processes (e.g., 510K, PMA, combination product) towards market approval. The aim of the present article is to summarise and explain the main statements made during the symposium, in terms of challenges and opportunities for medical device industries, in a constantly changing customer and regulatory environment.
引用
收藏
相关论文
共 50 条